In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

As NUCATS continues to champion translational research, grants like the Giddan Award ensure that pediatric health research ...

Due to the relatively inferior long-term patient outcomes, we recognize the need for improving our understanding of pediatric sarcomas, specifically osteosarcoma, Ewing sarcoma and rhabdomyosarcoma.

Associate Professor Fernando Guimaraes, a Principal Research Fellow from UQ's Frazer Institute led a team to develop new therapeutic strategies for hard-to-treat pediatric sarcomas that have high ...

The new approach establishes an opportunity to harness the success of immunotherapies that revolutionized the treatment of childhood leukemias for childhood brain cancers.